Clinical Trials in Salt Lake City

Showing 9401-9420 of 12,670 trials

Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence

NCT01848054

The purpose of the study was to assess the efficacy of induction treatment with buprenorphine/naloxone (BNX) sublingual tablet s compared with induction treatment with buprenorphine only. The hypothesis is that starting directly on OX219 works equally well (e.g. not significantly worse) as starting on buprenorphine only and switching to OX219 on Day 3.

Orexo AB313 participantsStarted Jun 2013

Birmingham, Alabama, United States • Haleyville, Alabama, United States • National City, California, United States +11 more locations

COMPLETEDPhase 3< 1 mile

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes

NCT02058160

Primary Objective: To demonstrate the superiority of the insulin glargine/lixisenatide fixed ratio combination (FRC) to insulin glargine in glycated hemoglobin (HbA1c) change from baseline to Week 30. Secondary Objective: To compare the overall efficacy and safety of insulin glargine/lixisenatide FRC to insulin glargine (with or without metformin) over a 30 week treatment period in participants with type 2 diabetes.

Type 2 Diabetes

Sanofi736 participantsStarted Jan 2014

Birmingham, Alabama, United States • Sun City, Arizona, United States • Tempe, Arizona, United States +233 more locations

Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes

Find Trials by Condition in Salt Lake City

Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration

Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma

The Safety of Using Buprenorphine With Naloxone in a Buccal Film to Initiate Treatment of Opioid Dependent Subjects

Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma

A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease

Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes

Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer

PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1

A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN)

Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma

Study of Antithymocyte Globulin for Treatment of New-onset T1DM

ESSENTIAL Trial™ Sham Cross-over

Roll-Over Protocol To Provide Atv And/Or Truvada For Extended Access

Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy

Educational Program for Various Health Literacy Levels to Improve the Health of Individuals With Heart Failure

Ovarian Cancer Vaccine for Patients in Remission

Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome

Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC